NCT00042562已完成3 期
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 23
研究概览
简要总结
The purposes of this study are to determine:
The safety of duloxetine and any side effects that might be associated with it.
Whether duloxetine can help patients with major depression.
The safety associated with switching from a medication you may be taking for depression to taking duloxetine.
It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •You must be at least 18 years old.
- •You must have been diagnosed with major depressive disorder.
- •You must be able to visit the doctor's office once a week to once every 2 weeks for a total of 14 weeks
排除标准
- •You are a woman and are pregnant or breastfeeding.
- •You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.
- •You have had a primary diagnosis of an anxiety disorder within the past 6 months.
- •You have a history of alcohol or drug dependence or abuse within the past 6 months.
研究者
研究点 (23)
Loading locations...
相似试验
Approved For Marketing
不适用
Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical TrialDiabetic Peripheral Neuropathic PainMajor Depressive DisorderFibromyalgiaGeneralized Anxiety DisorderNCT00071708Eli Lilly and Company
已完成
3 期
Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionMajor Depressive DisorderNCT00042575Eli Lilly and Company120
已完成
3 期
An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)Osteoarthritis of the KneeNCT02335346Eli Lilly and Company93
终止
3 期
A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive DisorderDepressive DisorderNCT03395353Shionogi151
已完成
3 期
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionDepressionNCT00073411Eli Lilly and Company675